Finance

Lists
Q2 2027 earnings • released • EPS beat +258.45% • Revenue beat +11.57%
See results
APLLTD:NSE
Alembic Pharmaceuticals Ltd
₹902.00
+12.36%
(+99.20) 1D
Nov 4, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APLLTD...
Open
₹808.00
High
₹963.35
Low
₹803.65
Mkt. cap
178.23B
Avg. vol.
162.34K
Volume
4.16M
Dividend
1.33%
Quarterly dividend
₹3.00
Ex-dividend date
Jul 29, 2026
P/E ratio
25.58
52-wk high
₹998.00
52-wk low
₹635.80
EPS
₹35.27
Shares outstanding
188.50M
No. of employees
17K
Open
₹808.00
High
₹963.35
Low
₹803.65
Mkt. cap
178.23B
Avg. vol.
162.34K
Volume
4.16M
Dividend
1.33%
Quarterly dividend
₹3.00
Ex-dividend date
Jul 29, 2026
P/E ratio
25.58
52-wk high
₹998.00
52-wk low
₹635.80
EPS
₹35.27
Shares outstanding
188.50M
No. of employees
17K
News stories
From web sources and news partners
About Alembic Pharmaceuticals Ltd
CEO-
Employees17.2K
Founded1907
Headquarters-
SectorPharmaceutical industry
Industry-
Website-
Last report
Just released
Today, 6:30 AM
Fiscal period
Q2 2027
₹39.31 / ₹10.97
+258.45%beat
Revenue / Est. (INR)
26.03B / 23.34B
+11.57%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.10B
18.76B
18.48B
21.50B
Cost of goods sold
5.16B
5.29B
6.27B
6.20B
Cost of revenue
5.16B
5.29B
6.27B
6.20B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.38B
4.33B
4.39B
4.74B
Operating expense
11.55B
11.34B
10.85B
12.96B
Total operating expenses
16.71B
16.63B
17.11B
19.16B
Operating income
2.40B
2.13B
1.36B
2.34B
Other non operating income
69.00M
154.90M
-285.60M
149.30M
EBT including unusual items
2.24B
1.61B
1.19B
2.22B
EBT excluding unusual items
2.24B
2.04B
1.37B
2.22B
Income tax expense
400.00M
295.40M
-829.00M
495.00M
Effective tax rate
17.88%
18.29%
-69.88%
22.31%
Other operating expenses
6.41B
6.21B
5.56B
7.24B
Net income
1.85B
1.33B
2.03B
1.73B
Net profit margin
9.67%
7.09%
10.97%
8.05%
Earnings per share
9.40
8.51
11.57
8.80
Interest and investment income
-
-
8.60M
-
Interest expense
-242.30M
-233.10M
-225.60M
-276.10M
Net interest expenses
-242.30M
-233.10M
-217.00M
-276.10M
Depreciation and amortization charges
760.70M
801.20M
885.90M
977.10M
EBITDA
3.15B
2.78B
2.12B
3.09B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps